All posts by imreal

Avalon Realty Associates Sponsors First GRIN2B Foundation Cocktail Reception Fundraiser


Avalon Realty Associates logo.

Avalon is proud to support the GRIN2B Foundation and happy to assist in an effort to help individuals and families impacted by GRIN2B.

Avalon Realty Associates – a full service commercial real estate company – has announced it will be one of the sponsors of GRIN2B Foundation’s first cocktail reception fundraiser, Gather for GRIN2B. The event will be held at Found Kitchen and Social House in Evanston on Monday, October 7 from 6 p.m. to 9 p.m.

Proceeds from the benefit will fund research on GRIN2B-Related Neurodevelopmental Disorder, which is caused by variations on the GRIN2B gene.

“Avalon is proud to support the GRIN2B Foundation and happy to assist in an effort to help individuals and families impacted by GRIN2B,” said Carlo Santucci, partner at Avalon Realty Associates.

GRIN2B is a gene on the short arm of the 12th chromosome. It’s part of a family of seven genes that encode proteins to form a receptor that relays chemical messages between neurons in the brain, according to GRIN2B Foundation. Individuals affected by a GRIN2B variation can experience developmental delays, speech delay or lack of speech, and low muscle tone, among other symptoms. Associated conditions can also include seizures, cortical visual impairment, Autism Spectrum Disorders, Attention Deficit Hyperactivity Disorder, and/or intellectual disabilities.

The GRIN2B Foundation is a parent-run organization committed to furthering research on the GRIN2B gene and to providing support for individuals and families affected by variations on the gene.

Some other corporate sponsors of Gather for GRIN2B include Stratosphere Networks, Little Steps Pediatric Therapy, Accounting Concepts, Lubin Austermuehle, P.C., and Rothman Law Group.

To get more information about Gather for GRIN2B and purchase tickets, please visit http://www.grin2b.org/Gather-For-GRIN2B/. Sponsorship information is available at http://grin2b.org/sponsor.

About Avalon Realty Associates

Avalon Realty Associates is a full service commercial real estate company that provides real estate brokerage, property investment, tenant representation and property management. For over 25 years, we’ve built trusting relationships with clients and partners and proudly provide real estate services throughout the country and to our community in the Chicago metro area. For more information, please visit https://avalonreal.com/.

For more information contact:

Carlo Santucci

847-506-1000

carlo@avalonreal.com

Share article on social media or email:

A New Article Explains How To Avoid Parking Lot Accidents


News Image

“Do not consider that if you are in a well=monitored public parking lot, you are safe. Parking lots accidents have become more common, mainly due to distracted driving”, said Russell Rabichev, Marketing Director of Internet Marketing Company.

Although they may look safe, parking lots can be quite hazardous, especially for inexperienced drivers. Official data from the National Safety Council shows that parking lot accidents are more common than one may think. This happens because many drivers are distracted when entering a parking lot. A fifth of car insurance accidents happen in parking lots. To find out more about car insurance, how to avoid accidents and to get free car insurance quotes, visit http://cheapquotesautoinsurance.com/.

For more info and free quotes, visit http://cheapquotesautoinsurance.com/parking-lots-and-car-accidents/

Distracted driving is the main reason why parking lots have become places where accidents happen frequently. A mall parking lot is usually surrounded by huge, flashy billboards. It is easy to lose focus when you are looking on a big screen where the latest offers and discounts are promoted. Keep focus on the road, park the car, then check the ads from a safe place. Also, turn off the smartphone when driving. Some people finding it amusing to take photos of billboards while they enter the parking lot.

Parking lots become crowded during winter holidays. The upcoming Christmas and New Year’s Eve will certainly bring crowds of people to malls and hypermarkets. This means more cars and pedestrians to worry about. With so many blind spots inside a parking lot, the risk of causing an accident is exponentially increased. Pay attention to existing blind spots and slow down. Also consider installing proximity sensors and blind-spot monitors.

Cheapquotesautoinsurance.com is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.

For more information, please visit http://cheapquotesautoinsurance.com/.

Share article on social media or email:

OCT Clinical Trials Appoints Maxime Stevens as Chief Strategy and Development Officer; Poises for Global Expansion


Maxime Stevens

OCT Clinical Trials announced that it has appointed Maxime Stevens as Chief Strategy and Development Officer.

“I look forward to supporting both strategic onward growth and success of the company, and inspiring our people to learn even more, and become even more.” — Maxime Stevens, Chief Strategy and Development Officer, OCT Clinical Trials

OCT Clinical Trials, a leading CRO with operations in Eastern Europe, today announced that it has appointed Maxime Stevens as Chief Strategy and Development Officer. In her role, she is responsible for establishing business development vision, creating roadmaps for global expansion, driving operational excellence and leading short- and long-term global strategy growth operations for the entire company.

“It is both an honor and pleasure for me to be joining OCT Clinical Trials as their Chief Strategy and Development Officer,” Stevens said. “The people are extremely skilled, experienced and passionate about not only our work, but also each other, our sponsors and our partners.”

Maxime brings more than 25 years’ experience in executive leadership, developing Global BD and Operations groups for both American and European companies, including United States Surgical Corporation, Cyberonics Inc., Pierrel Research International AG and Optimapharm. As CEO for Pierrel Research International AG, Maxime was instrumental in wholly restructuring a troubled global company with 28 offices, increasing investments, backlog and revenue pipelines by more than 200%, and securing SIX Swiss Exchange listing of the merged companies in 2014.

Maxime possesses a strong track record of driving long-term growth, operational excellence and expansion of new geographic and channel opportunities for prominent players in the industry. Her extensive international experience, most notably in MENA, Africa, Europe and the United States, is a valuable asset for OCT Clinical Trials as the company moves toward global expansion.

Maxime is also known for her seven-year period running operations for South Africa’s branch of the World Health Organization (WHO). Maxime was recognized by WHO for Outstanding Contribution to Ethics in Business and Humanity, and was an Honored Member of International WHO’s WHO of Professionals in both 2013 and 2014. She also sat for four years on the FDA advisory and ethical boards for Innovative Medical Device approvals.

“I look forward to supporting both strategic onward growth and success of the company, and inspiring our people to learn even more, and become even more. Our best work happens when we embrace making a difference — and then we achieve it,” Maxime added.

Having already gained a sizable market share of trials in Eastern Europe and CIS region, OCT is now taking the significant step of expanding its presence into EMEA, Israel, South Africa, Europe and the United States. With this strategic reinforcement, they will continue to provide the tailor-made solutions they are already known for, now to a broader pool of pharma, biotech and medical device companies.

“We’re a full-service CRO with over 300 projects in our portfolio, solid technological infrastructure and well-run processes with all the main sites within the Eastern European and CIS region,” said Dmitry Sharov, OCT Group President. “We realize that our services and approach are in high demand, not only for sponsors within the region, but for companies worldwide. Maxime Stevens has the proven experience and expertise to strategically develop and drive our expertise into the global arena, and amplify the image of a CRO with an impeccable reputation.”

About OCT Clinical Trials

OCT Clinical Trials is the leading CRO in Russia, with operations in Central and Eastern Europe and the CIS region. With a team of over 200 professionals, the company provides a full range of high-quality clinical research services for phase I-IV and BE studies. With strong local expertise and focus on quality, OCT ensures seamless clinical trial conduct and drug registration on time and within budget. OCT’s experienced team delivers both standalone services such as medical writing, consultancy, project management/monitoring, data management/biostatistics and turnkey service for clinical development. Since 2005, OCT Clinical Trials has worked on over 300 full-service and functional service projects in more than 20 therapeutic areas. Learn more at http://www.OCT-ClinicalTrials.com.

Share article on social media or email:

Mattax Neu Prater Eye Center Now Offering First Trifocal Lens for Cataract Patients


Jacob Thomas, MD, of Mattax Neu Prater Eye Center

Jacob Thomas, MD, of Mattax Neu Prater Eye Center

It’s truly one-of-a-kind and may be very helpful for those whose lifestyle requires more complete vision.

Mattax Neu Prater Eye Center now offers its cataract patients the AcrySof® IQ PanOptix® Trifocal Lens, the first and only trifocal intraocular replacement lens (IOL) available in the United States. Implanted during cataract surgery, the PanOptix lens is designed to provide a full range of vision with less dependence on glasses and contacts. This full range includes clear vision at near (e.g. looking at a cell phone), intermediate (e.g. looking at a computer screen), and far (e.g. watching television) distances.

“Cataract correction technology is constantly evolving, so our team is always monitoring these advancements,” says eye surgeon Dr. Jacob Thomas of Mattax Neu Prater. “When we select a new device for our patients, it’s because we believe it’s the most beneficial option for them, not simply because it’s the newest. That is why we are so excited to introduce our cataract patients to the PanOptix trifocal lens. It’s truly one-of-a-kind and may be very helpful for those whose lifestyle requires more complete vision.”

Those interested in learning more about the advanced technology PanOptix IOL should request a cataract consultation by calling Mattax Neu Prater Eye Center at (417) 886-3937 or visiting MattaxNeuPrater.com.

ABOUT MATTAX NEU PRATER EYE CENTER

With five locations in Springfield, Lebanon, Monett, Mountain Grove, and Branson, as well as an onsite surgery center within the Springfield office, Mattax Neu Prater serves patients across the Ozarks. Together, they provide surgical, medical, and primary vision care, including:


  • LASIK laser vision correction
  • Laser-assisted cataract correction with advanced replacement lenses
  • Treatment for glaucoma, diabetic retinopathy, macular degeneration, cornea conditions, and dry eyes
  • Comprehensive eye exams, optical services, and contact lenses

To learn more or request an appointment at Mattax Neu Prater Eye Center, call (417) 886-3937 or visit MattaxNeuPrater.com.

Share article on social media or email:

Improved Pharma at AAPS with Rapid Fire Presentation, Poster, and Booth


Improved Pharma at AAPS with Rapid Fire Presentation

A lot of things have changed since we started SSCI, and we still believe in face-to-face interactions with other scientists to discuss research problems and solutions. Now with our new company, Improved Pharma, we are renting a 10 by 10 booth near the posters and will start the process again

Improved Pharma LLC will be presenting their latest research in the area of high-level X-ray methods using synchrotron-produced X-rays to study amorphous drug formulations. On Monday, November 4th, Dr. Pamela Smith, COO of Improved Pharma, will present “Synchrotron X-Ray Diffraction and Pair Distribution Function Analysis of Drug/Polymer Dispersions: A Comparison of Subtraction Techniques to Isolate Intra- and Intermolecular Interactions”. The poster will be presented from 11:30 AM to 12:30 PM in Poster Forum 6. The full abstract of the poster can be accessed here.

On Tuesday, November 5th, Dr. Smith will present “Synchrotron X-ray Analysis of Amorphous Drugs and Drug:Polymer Dispersions” in the Rapid Fire: Formulation and Quality – Chemical session. The session takes place in Exhibit Hall 234 from 3:00 PM to 5:00 PM. Much of our research focuses on using synchrotron X-ray Pair Distribution Function (SXPDF) techniques to probe atom-atom distances in amorphous materials and dispersions. Not all amorphous materials are equivalent, and the PDF patterns reflect the degree of disorder in the materials. SXPDF can provide important regulatory information regarding the sameness of various formulations or lots prepared using different techniques (e.g. spray drying and melt extrusion). SXPDF can also detect neighboring drug molecules in a drug-polymer dispersion. If present, the dispersion is more likely to crystallize as compared to dispersions where no drug domains are detected. This information is extremely important, especially when assessing the risk of a formulation undergoing unwanted changes during manufacturing, scale-up, or storage. SXPDF can also help guide improved formulations of existing products, extending intellectual property protections.

Improved Pharma will be exhibiting in booth 551, conveniently located in the Formulation and Quality section next to Poster Forum 2. We look forward to meeting with you to discuss the latest advances in pharmaceutical research and development. Have a problem with solubility or bioavailability? Want to reformulate your drug product? Looking for assistance with patent litigation? Or, do you just need some analytical testing services? Feel free to stop by to see if we can help you. If you’d like to book an appointment or have a discussion prior to the meeting, please contact us at info@improvedpharma.com.

Stephen Byrn, CSO of Improved Pharma, has a long history associated with the AAPS meeting and was featured as the Member Spotlight of the August 2019 issue of AAPS News Magazine. You can read the article here. As noted in the article, Byrn successfully launched his first business (SSCI) through AAPS. He stated: “My wife and I started our company with only two people. We purchased the AAPS mailing list and taught short courses, both on our own and through AAPS. After we opened our lab, we rented a 10-foot by 10-foot booth near the posters, and I stood in the walkway and told people why they needed our services since we were a research and information company. We eventually grew to 100 employees and sold the company in 2006. Some of the funds from the sale helped fund our work in Africa, especially in the early days. Now we’ve started a new research and information company called Improved Pharma. Although a lot of things have changed since we started our first company, we are still going to rent a 10-foot by 10-foot booth near the posters at this year’s AAPS meeting and start the process all over again.”

About Improved Pharma

Improved Pharma is a research and information company dedicated to improving pharmaceutical methods, formulations, and processes. Dr. Stephen Byrn and Sarah Byrn founded the company in 2006 after the successful acquisition of their first company, SSCI. Dr. Pamela Smith joined the company in 2018 after an 18-year tenure with SSCI. Improved Pharma offers services such as analytical testing, synchrotron-based formulation design, and expert consulting aiding the development and defense of intellectual property matters.

For more information about the techniques discussed in this press release or about Improved Pharma’s services, please contact us at 1-765-463-9951 or info@improvedpharma.com.

Share article on social media or email:

Rigaku presents its X-ray analytical instrumentation at ESSDERC / ESSCIRC 2019


Rigaku TXRF-V310 for ultra-trace measurement of elemental surface contamination

Rigaku TXRF-V310 semiconductor metrology tool for ultra-trace analysis of elemental surface contamination

Rigaku, a leading supplier of X-ray metrology tools, is the sole Diamond sponsor of the event and is a pioneer and world leader in designing and manufacturing X-ray based measurement tools to solve semiconductor manufacturing challenges.

Rigaku Corporation, a global leader in X-ray analytical technology, is pleased to announce its attendance at the joint meeting of the 49th European Solid State Device Research Conference (ESSDERC) and 45th European Solid State Circuits Research Conference (ESSCIRC). ESSDERC/ESSCIRC is taking place Monday, September 23, through Thursday, September 26, 2019 at the Jagiellonian University Auditorium Maximumin in Kraków, Poland.

The conferences provide an annual European forum for the presentation and discussion of recent advances in solid-state devices and circuits. The increasing level of integration for system-on-chip design made available by advances in semiconductor technology requires a deeper interaction among technologists, device experts, and designers of integrated circuits and systems. While keeping separate Technical Program Committees, ESSDERC and ESSCIRC are governed by a common Steering Committee and share Plenary Keynote Presentations and Joint Sessions bridging both communities.

Rigaku, a leading supplier of X-ray metrology tools, is the sole Diamond sponsor of the event and is a pioneer and world leader in designing and manufacturing X-ray based measurement tools to solve semiconductor manufacturing challenges.

With over 35 years of global market leadership in the semiconductor industry, Rigaku solutions employ X-ray fluorescence (XRF), diffraction (XRD), and reflectometry (XRR) techniques and enable everything from in-fab process control metrology to R&D for thin film and materials characterization, as well as total-reflection XRF spectrometers (TXRF) with integrated vapor phase decomposition (VPD) for trace contamination monitoring.

Systems of note from Rigaku include the Rigaku TXRF-V310 semiconductor metrology system for ultra-trace analysis of elemental surface contamination. The tool employs TXRF analysis for measuring contamination in all fab processes, including cleaning, litho, etch, ashing, and films, It can measure elements from sodium (Na) through uranium (U) with a single-target, 3-beam X-ray system and a liquid nitrogen-free detector system.

The Rigaku MFM310 system is designed for high-volume manufacturing and performs high-precision measurements not possible by optical or ultrasonic techniques. A sophisticated X-ray metrology tool, it enables performance of high-throughput measurements on product and blanket wafers, ranging from ultrathin single-layer films to multilayer stacks.

Also featured is the next-generation Rigaku SmartLab intelligent multipurpose X-ray diffractometer with SAXS and in-plane capabilities. It features the brand new PhotonMax high-flux 9 kW rotating anode X-ray source coupled with a Rigaku HyPix-3000 high-energy-resolution 2D multidimensional semiconductor detector that supports 0D, 1D and 2D measurement modes. The system incorporates a high-resolution θ/θ closed loop goniometer drive system with an available in-plane diffraction arm.

More information about X-ray based measurement tools from Rigaku for semiconductor manufacturing is available at http://www.rigaku.com/products/isemi.

About Rigaku

Since its inception in Japan in 1951, Rigaku has been at the forefront of analytical and industrial instrumentation technology. Rigaku and its subsidiaries form a global group focused on general-purpose analytical instrumentation and the life sciences. With hundreds of major innovations to their credit, Rigaku companies are world leaders in X-ray spectrometry, diffraction, and optics, as well as small molecule and protein crystallography and semiconductor metrology. Today, Rigaku employs over 1,400 people in the manufacturing and support of its analytical equipment, which is used in more than 70 countries around the world supporting research, development, and quality assurance activities. Throughout the world, Rigaku continuously promotes partnerships, dialog, and innovation within the global scientific and industrial communities.

For further information, contact:

Michael Nelson

Rigaku Global Marketing Group

tel: +1. 512-225-1796

michael.nelson@rigaku.com

Share article on social media or email:

Smile Design Studios Named 2019 Top Patient Rated Missouri City Dentist by Find Local Doctors


News Image

We are so pleased to be recognized as a Top Patient Rated Dentist. We strive to provide an elevated dental experience where both the health and comfort of patients are priorities. Our team offers superior care, using the best that modern dentistry has to offer, says Dr. Simone Ellis.

Find Local Doctors recently honored Smile Design Studios as a 2019 Top Patient Rated Missouri City Dentist. This designation is based on superior ratings and reviews from actual patients. Find Local Doctors is a trusted online directory that helps consumers easily locate qualified and reputable physicians and dentists in their area. Smile Design Studios is among a premier group of dental practices receiving a large number of five-star, positive patient reviews from reputable online sources.

Smile Design Studios, Family and Cosmetic Dentistry, is located at 6130 Highway 6, Missouri City, TX. Dr. Simone Ellis’s modern, state-of-the-art dental practice is equipped to address all aspects of your oral health at every stage of life. Smile Design Studio’s menu of dental services includes ways to protect and restore your teeth. This is as well as offering advanced, cutting-edge treatments to help patients attain healthy, balanced and beautiful smiles. Smile Design Studios is a professional dental practice offering cosmetic dentistry, restorative dentistry and general dentistry services such as teeth whitening, veneers, Invisalign and so much more.

When it comes to your smile, Smile Design Studios stops at nothing less than excellence. Patient reviews mention the friendly, thorough and prompt service provided by Dr. Ellis and her team. The warm, welcoming environment and expert dental care help patients feel at home and make this practice stand out from the rest.

“We are so pleased to be recognized as a Top Patient Rated Dentist. We strive to provide an elevated dental experience where both the health and comfort of patients are priorities. Our team offers superior care, using the best that modern dentistry has to offer,” says Dr. Simone Ellis.

Dr. Simone Ellis earned her Doctor of Dental Medicine degree from Rutgers University School of Dentistry. She is the founder and president of the Houston Minority Dental Society and is an active member of the American Dental Association (ADA), National Dental Association (NDA), American Academy of Implant Dentistry (AAID) and the Greater Houston Dental Society (GHDS). Additionally, Simone is a certified clinical evaluator for The Clinician’s Report and a candidate for Diplomat with the American Academy of Implant Dentistry.

For more information about Smile Design Studios in Missouri City, TX, or to schedule an appointment, please visit http://www.sdshouston.com or call (281)-969-7388.

Share article on social media or email:

Laser Society to Host 10th Annual Laser Aesthetics Course in December


Photo of Gerald Goldberg, MD

Gerald N. Goldberg, MD

What is special about this meeting is the high-quality didactic lectures with a great faculty and the small group feel which maximizes the participant experience and creates a stimulating interactive learning environment.

The latest techniques and treatments in aesthetic laser medicine will be presented at the 10th Annual ASLMS Laser Aesthetics Course on December 7-8, 2019 in Tucson, Arizona.

This popular weekend course, hosted by the American Society for Laser Medicine & Surgery, Inc. (ASLMS), is designed for dermatologists, other specialists, general practitioners, nurses, physician’s assistants, and medical aesthetic personnel who use or are investigating the use of lasers and other energy-based technologies.

Faculty includes key ASLMS thought leaders Gerald N. Goldberg, MD, course director, and J. Stuart Nelson, MD, PhD; E. Victor Ross, MD; and Emil A. Tanghetti, MD.

“We will have a new format with a full one-day thorough laser didactic session, followed by a unique half-day session highlighting live patient laser demonstrations, and some opportunity to have some “hands-on” training with a variety of laser devices,” said Goldberg. “The hands-on training will take place in an intimate private practice clinic small group setting, with expert clinical faculty. The course will have a limited enrollment to maximize participant-faculty interaction and learning, which has been a hallmark of this meeting over the years.”

This year the course will be held in Tucson, Arizona. Day one sessions will take place at the Sheraton Tucson and the day two laser demonstrations will be held at Goldberg’s Pima Dermatology Clinic in Tucson.

The course provides a broad overview of devices used in aesthetic applications to achieve optimum clinical outcomes. Topics include: Non-Ablative Rejuvenation, IPL, Microneedling and RF Microneedling, Laser Treatment of Vascular Lesions, Pigmented Lesions, Scars, Tattoos and Ethnic Skin, Laser Hair Removal, Fractional Ablative and Full Field Ablative CO2 and Erbium Resurfacing, Non-Invasive Body Contouring, Fat Reduction, Skin Tightening, Laser Complications and Laser Safety, Combining Lasers and Devices to Enhance Outcomes, and Combining Laser and Energy Sources with Cosmetic Injectables.

“What is special about this meeting is the high-quality didactic lectures with a great faculty and the small group feel which maximizes the participant experience and creates a stimulating interactive learning environment, said Goldberg. “The added bonus this year is to include some live patient demonstrations as well as an opportunity to have some “hands-on” experience with a number of lasers in a private practice clinical setting.”

Dr. Gerald N. Goldberg is an internationally recognized dermatologist with unique experience in laser surgery spanning more than 3 decades. Being board-certified in pediatrics and dermatology he has a special interest and expertise in the laser treatment of vascular birthmarks in children as well as in laser skin resurfacing.

For over 35 years, Dr. Goldberg has been in private practice at Pima Dermatology in Tucson, Arizona and works in a state of the art facility providing comprehensive dermatologic services spanning medical, surgical, cosmetic, and laser dermatology.

Pre-registration is required. Course registration fees range from $1050 for ASLMS members to $1400 for non-members. A limited number of seats are available for residents and fellows-in-training at a reduced fee. To register, or for more information, visit https://www.aslms.org/for-professionals/education-center/laser-aesthetics-course, call (877) 258-6028 or email information@aslms.org

The American Society for Laser Medicine and Surgery, Inc. (ASLMS) is the largest multi-disciplinary professional organization dedicated to the development and application of lasers and related technology for health care applications. ASLMS promotes excellence in patient care by advancing biomedical application of lasers and other related technologies worldwide. ASLMS members include physicians and surgeons representing more than 35 specialties, physicists involved in product development, biomedical engineers, biologists, nurses, industry representatives, and manufacturers. For more information, visit http://www.aslms.org/

Share article on social media or email:

Online Quotes Will Help Drivers Stop Overpaying For Car Insurance


News Image

“The carrier that once offered the best prices on the market may now try to push really expensive premiums. This happens because you are a loyal customer and they think it’s unlikely to switch carriers. Use online quotes and avoid overpaying”, said Russell Rabichev, Marketing Director of IMC

Overpaying for auto insurance is a big problem for drivers. After all, car insurance tends to be an expensive investment on its own. Adding hidden fees or price optimization can cause serious financial problems. The best way to investigate whether the price is too high or not is to use car insurance online quotes. Drivers can get them for free from http://compare-autoinsurance.org

For more info about car insurance and money-saving tips, visit http://compare-autoinsurance.org/how-to-determine-if-you-overpay-for-car-insurance/

Take into consideration the following facts when analyzing the current coverage costs. They will help the driver determine if he overpays or not for auto insurance.


  • Check for current car insurance market trends . It is wise to check the insurance market every 6 months and with at least 1 month before renewal. If the driver has not checked the market in the past year, there are many chances to be overpaying. Many insurance company count of drivers not reviewing the market and increase the premiums every 6 months.
  • Carefully scan the contract for hidden fees. It may be time-consuming and boring to read every line of the contract. But behind every line and ambiguous phrase or term can hide additional fees. Call an insurance agent and ask him to explain every term or phrase that is hard to understand.
  • Some insurance companies charge extra loyal customers. Some companies practice a controversial technique called “price optimizations”. This involves analyzing data on consumers to find out who will shop around and who won’t. If a computer algorithm estimates that a person is unlikely to shop around, his premiums could likely go up. Companies use it to squeeze more profit out of policies and they often charge more in rates the longer the person has been a loyal customer because they’re relatively confident that he won’t switch companies.

Compare-autoinsurance.org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.

For more information, please visit http://compare-autoinsurance.org

Share article on social media or email:

New CEO Study from Leaders On Purpose Reinforces The Role Corporate Purpose Plays In Reimagining Capitalism


https://www.prweb.com/

Leaders On Purpose 2019 Study

The role of traditional capitalism is being questioned as never before. An economic system borne of the industrial age is currently threatening the extinction of life on earth, creating massive wealth disparities, and contributing to social injustice on a global scale.

The 2019 Leaders on Purpose CEO study provides fresh insight into the changing role of business in society and suggests some productive best practices for transforming capitalism. The report features interviews with CEOs from BMW, PayPal, Mastercard, Siemens, Kohler and many other businesses that are no longer treating social responsibility as an add-on. Instead, they are building purpose into the core of their business strategies. Building off our 2018 study, this new report delves deep into many issues including systems thinking, new models for cross-sectoral partnering, harnessing the unexpected and how new organizational models are unleashing employee engagement.

“All 30 CEOs talk about the tremendous leverage effect they’ve experienced by aligning their business growth objectives with the goal of promoting global wellbeing,” says Christa Gyori, CEO of Leaders on Purpose. “By recognizing the world as a holistic system of interrelated issues, these companies have been able to evolve faster, innovate more effectively and create and sustain long-term relationships with their employees, customers and partners.”

The five findings from the 2019 study are:

1. Companies with an established and embedded corporate purpose have a more comprehensive perspective of today’s challenges, allowing for clearer decisions and stronger future fitness. Today’s businesses operate amid expected and unexpected evolutionary pressures: collapsing industries, distrust of institutions, automation, artificial intelligence, rising inequality, demographic shifts, climate change, resource depletion and more. Not surprisingly, many leaders and organizations find it difficult to respond to this unprecedented rate of change. However, those that embrace the issues they can positively impact, find themselves better equipped to predict challenges and to pivot their businesses to capture opportunities, foster innovation and bolster their resilience.

For example, Turkish telecom giant, TurkCell saw the headwinds of the regional refugee crisis: overloaded cellular systems caused by displaced people desperate to connect with friends and family. The company quickly adjusted its network, provided free phones to people in need and reduced tensions in camps across the country. Their fast, forward-thinking action resulted in an expansion of their customer base, increased loyalty and an uptake in sales.

2. CEOs with a purpose agenda are entrepreneurial, push boundaries of short termism and aspire to transform industries, not just markets. Corporate leaders that embrace a globally anchored purpose understand the significance of an institutionalized long-term growth perspective. In fact, they come to view this as a necessity for both organizational competitiveness and transformation in the digital era. These CEOs lead by example, maintaining an operationally anchored leadership mindset and a consistent purpose-driven approach. What’s more, they understand that employee empowerment is more than a trigger for employee satisfaction; it is an effective way to unleash capabilities for market-leading and pioneering innovation.

Interface CEO, Jay Gould, demonstrates these traits as he continues to implement the same approach to business pioneered when the company first embraced purpose almost 25 years ago. A recent example of this is Interface’s global distribution of innovative carbon-negative products that actually capture more carbon than they use.

3. Corporate purpose agendas require new kinds of cross-sectoral partnerships to support bold goals, tackle big challenges and scale innovation faster. Alignment around a comprehensive approach to purpose allows companies to transform stakeholders into powerful long-term partners while fostering pre-competitive, non-traditional partnerships. While traditional businesses struggle with incremental improvements rather than incubating the next big thing, purpose-led companies set more ambitious long-term goals. These big picture initiatives present opportunities for new types of partnership, cross-sectoral collaboration and innovation. The CEOs in our 2019 study believe getting to scale with speed is an imperfect process. Instead, they foster a ‘test and learn’ environment and seek non-traditional partners and open-source capabilities to generate better ideas.

Paypal CEO, Dan Schulman, believes constant learning is critical, and that failure can lead to discovery. The company’s acceptance that things won’t always go to plan is critical to its ability to innovate and grow as a business, while its purpose-led agenda fosters a problem-solving approach.

4. Purpose-led CEOs embrace the essential role of the unexpected. The CEOs in our 2019 study recognize that the unexpected is often an opportunity rather than a threat. Hubert Joly, Chairman of Best Buy, remarks, “Dealing with the unexpected and seizing those as moments of truth is a very powerful idea. It is in those [unexpected] moments that you can really make a difference.” In Best Buy’s case, one such unexpected event was Hurricane Maria. The company responded to this crisis by organizing private planes, flying in food and water, and offering to evacuate employees. This approach spoke volumes about their values and the resulting increase in customer and employee loyalty has, in turn, increased Best Buy’s revenues.

5. Organizational agility empowers employees, enables a greater flow of ideas and supports innovation. Most of the CEOs featured in our 2019 study consider organizational agility the most important characteristic of a successful, purpose-driven organization. As such, many of them are taking steps to drastically reduce corporate hierarchy in an effort to boost agility. Most have already introduced a flatter structure to become more adaptive. All 30 CEOs were intensely focused on the motivation, engagement and collective intelligence of their employees.

David Kohler, CEO of Kohler, explains, “We look at measurements overall as a company, and regionally, and by business, but the greatest success is when the associates in an organization are driving the agenda on a self-directed passionate basis… We’ve learned a lot about organizational change, and you can’t mandate this. The power is in the passion of the enterprise. People genuinely want to do good things.” Organizational structures that reduce resistance to change empower and incent employees to fully engage with the driving purpose of their business.

Participating CEOs include:

CEO    Carlos Brito    AB InBev

CEO    Brian Duperreault    AIG

CEO    Hubert Joly    Best Buy

CEO    Herald Kruger    BMW

CEO    Tom Linebarger    Cummins

CEO    Emmanuel Faber    Danone

CEO    Remi Eriksen    DNV-GL

CEO    Feike Sijbesma    DSM

CEO    Zhang Ruimin    Haier

CEO    Peter Agnefjall    IKEA

CEO    Pablo Isla    Inditex

CEO    Jay Gould    Interface

CEO    Barry Rafferty    Ketchum

CEO    David Kohler    Kohler

BoD    Laura Kohler    Kohler

CEO    Jean Paul Agon    Loreal

CEO    Anand Mahindra    Mahindra & Mahindra

CEO    Grant Reid    Mars

CEO    Ajay Banga    Mastercard

CEO    Lars Sorensen    Novo Nordisk

CEO    David Taylor    Proctor & Gamble

CEO    Dan Schulman    PayPal

CEO    John Fallon    Pearson

CEO    Frans van Houten    Philips

CEO    Johan Torgeby    SEB

CEO    Joe Kaeser    Siemens

CEO    Denis Machuel    Sodexo Global

CEO    Lorna Donatone    Sodexo North America

CEO    Kaan Terzioğlu    Turkcell

Share via Twitter, Facebook, Instagram, LinkedIn

Find the full study here: Leaders on Purpose 2019 CEO Study.

For more information contact Monica Marshall at monica.marshall@ruderfinn.com.